SM
Sripada Maha Lakshimi
About Sripada Maha Lakshimi
Data last updated:
Sripada Maha Lakshimi has 31 years in corporate governance. Holds Director role. Currently with 3 companies, including Sylon Bio Pharma Private Limited and Avian Life Sciences Private Limited. Engaged in General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹13.98 Cr; the largest is Sylon Bio Pharma Private Limited at ₹9.22 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sylon Bio Pharma Private Limited U24232TG2006PTC051758 | Director | 25 Feb 2021 | 2006 | ₹9.22 Cr (FY 2025) | Active |
| Avian Life Sciences Private Limited U24232TG2011PTC075339 | Director | 23 Jun 2021 | 2011 | ₹4.66 Cr (FY 2025) | Active |
| Deal Well Chit Fund Private Limited U65992TG1995PTC021647 | Director | 07 Sep 1995 | 1995 | ₹0.09 Cr (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sripada Maha Lakshimi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sripada Maha Lakshimi
Sripada Maha Lakshimi has 31 years in corporate governance. Holds Director role. Currently with 3 companies, including Sylon Bio Pharma Private Limited and Avian Life Sciences Private Limited. Engaged in General Business. Contributes to corporate operations. The 3 current companies with reported revenue have a combined latest revenue of ₹13.98 Cr; the largest is Sylon Bio Pharma Private Limited at ₹9.22 Cr (FY 2025).
Sripada Maha Lakshimi is associated with 3 companies as Director, including Sylon Bio Pharma Private Limited (₹9.22 Cr), Avian Life Sciences Private Limited (₹4.66 Cr), Deal Well Chit Fund Private Limited (₹0.09 Cr).
Sripada Maha Lakshimi has expertise in General Business.
Sripada Maha Lakshimi has 31 years in corporate governance.
By reported revenue, the largest current company of Sripada Maha Lakshimi is Sylon Bio Pharma Private Limited, with revenue of ₹9.22 Cr (FY 2025).
The 3 current companies of Sripada Maha Lakshimi that report revenue have a combined latest revenue of ₹13.98 Cr.
Sripada Maha Lakshimi currently holds positions at 3 companies: Sylon Bio Pharma Private Limited (₹9.22 Cr), Avian Life Sciences Private Limited (₹4.66 Cr), Deal Well Chit Fund Private Limited (₹0.09 Cr).